-
Fund Dashboard
- Holdings
PROFUND VP BIOTECHNOLOGY
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
NBIX Neurocrine Biosciences, Inc. | 917.96 k | 6.73 k shares | 2.54 | Common equity | Long | USA |
ABBV AbbVie Inc. | 878.73 k | 4.95 k shares | 2.43 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 862.18 k | 9.33 k shares | 2.39 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 859.16 k | 13.07 k shares | 2.38 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 840.11 k | 2.38 k shares | 2.32 | Common equity | Long | USA |
BIIB Biogen Inc. | 837.39 k | 5.48 k shares | 2.32 | Common equity | Long | USA |
MRNA Moderna, Inc. | 836.55 k | 20.12 k shares | 2.31 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 836.17 k | 6.88 k shares | 2.31 | Common equity | Long | USA |
AMGN Amgen Inc. | 821.80 k | 3.15 k shares | 2.27 | Common equity | Long | USA |
INCY Incyte Corporation | 821.66 k | 11.90 k shares | 2.27 | Common equity | Long | USA |
NTRA Natera, Inc. | 816.83 k | 5.16 k shares | 2.26 | Common equity | Long | USA |
INSM Insmed Incorporated | 802.31 k | 11.62 k shares | 2.22 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 798.41 k | 3.39 k shares | 2.21 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 794.96 k | 1.12 k shares | 2.20 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 775.30 k | 9.47 k shares | 2.14 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 767.16 k | 13.65 k shares | 2.12 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 741.77 k | 1.84 k shares | 2.05 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 700.94 k | 17.42 k shares | 1.94 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 664.85 k | 13.91 k shares | 1.84 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 656.64 k | 2.13 k shares | 1.82 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 640.77 k | 21.29 k shares | 1.77 | Common equity | Long | USA |
Invesco Government & Agency Portfolio | 574.37 k | 574.37 k shares | 1.59 | Short-term investment vehicle | Long | USA |
ADMA ADMA Biologics, Inc. | 565.28 k | 32.96 k shares | 1.56 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd. | 541.52 k | 45.78 k shares | 1.50 | Common equity | Long | Bermuda |
IONS Ionis Pharmaceuticals, Inc. | 532.97 k | 15.25 k shares | 1.47 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 499.33 k | 10.62 k shares | 1.38 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 498.03 k | 5.71 k shares | 1.38 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 494.96 k | 15.51 k shares | 1.37 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 485.47 k | 11.10 k shares | 1.34 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 453.11 k | 13.61 k shares | 1.25 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 441.07 k | 16.07 k shares | 1.22 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 419.22 k | 10.65 k shares | 1.16 | Common equity | Long | Switzerland |
Alkermes Plc | 387.20 k | 13.46 k shares | 1.07 | Common equity | Long | Ireland |
SMMT Summit Therapeutics Inc. | 357.29 k | 20.02 k shares | 0.99 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 349.94 k | 4.56 k shares | 0.97 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 330.58 k | 11.37 k shares | 0.91 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 324.50 k | 8.69 k shares | 0.90 | Common equity | Long | Virgin Islands (British) |
NUVL Nuvalent, Inc. | 298.09 k | 3.81 k shares | 0.82 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 285.35 k | 7.90 k shares | 0.79 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 278.59 k | 6.00 k shares | 0.77 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 273.75 k | 6.51 k shares | 0.76 | Common equity | Long | USA |
GERN Geron Corporation | 273.69 k | 77.31 k shares | 0.76 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 273.69 k | 1.75 k shares | 0.76 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 266.85 k | 5.22 k shares | 0.74 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 263.40 k | 35.59 k shares | 0.73 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 258.56 k | 38.25 k shares | 0.72 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 253.46 k | 10.76 k shares | 0.70 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 247.47 k | 9.79 k shares | 0.68 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 238.22 k | 5.63 k shares | 0.66 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 236.73 k | 6.13 k shares | 0.65 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 229.88 k | 5.81 k shares | 0.64 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 226.24 k | 5.01 k shares | 0.63 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 216.79 k | 5.02 k shares | 0.60 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 212.98 k | 11.11 k shares | 0.59 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 204.38 k | 16.01 k shares | 0.57 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 201.73 k | 21.42 k shares | 0.56 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 197.42 k | 11.33 k shares | 0.55 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 195.19 k | 7.60 k shares | 0.54 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 191.94 k | 4.27 k shares | 0.53 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 191.14 k | 16.39 k shares | 0.53 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 188.21 k | 13.51 k shares | 0.52 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 185.55 k | 7.49 k shares | 0.51 | Common equity | Long | USA |
NVAX Novavax, Inc. | 185.00 k | 23.01 k shares | 0.51 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 184.99 k | 9.08 k shares | 0.51 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 181.21 k | 3.24 k shares | 0.50 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 179.41 k | 3.35 k shares | 0.50 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 177.08 k | 9.65 k shares | 0.49 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 176.97 k | 7.14 k shares | 0.49 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 174.14 k | 34.35 k shares | 0.48 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 167.79 k | 3.70 k shares | 0.46 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 166.23 k | 2.16 k shares | 0.46 | Common equity | Long | USA |
CDNA CareDx, Inc | 164.75 k | 7.70 k shares | 0.46 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 163.67 k | 8.71 k shares | 0.45 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals, Inc. | 156.96 k | 7.52 k shares | 0.43 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 151.29 k | 11.44 k shares | 0.42 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 148.43 k | 4.52 k shares | 0.41 | Common equity | Long | USA |
VCEL Vericel Corporation | 147.05 k | 2.68 k shares | 0.41 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 147.00 k | 3.65 k shares | 0.41 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 146.30 k | 10.67 k shares | 0.40 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 145.03 k | 5.06 k shares | 0.40 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 140.60 k | 7.46 k shares | 0.39 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 129.75 k | 4.66 k shares | 0.36 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 129.74 k | 10.24 k shares | 0.36 | Common equity | Long | USA |
MNKD MannKind Corporation | 128.68 k | 20.01 k shares | 0.36 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 126.18 k | 10.04 k shares | 0.35 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 119.96 k | 2.90 k shares | 0.33 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 114.75 k | 4.93 k shares | 0.32 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 113.43 k | 15.08 k shares | 0.31 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 112.98 k | 1.78 k shares | 0.31 | Common equity | Long | USA |
CAPR Capricor Therapeutics, Inc. | 111.97 k | 8.11 k shares | 0.31 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 95.12 k | 9.02 k shares | 0.26 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 90.43 k | 35.32 k shares | 0.25 | Common equity | Long | USA |
EBS Emergent BioSolutions Inc. | 88.87 k | 9.30 k shares | 0.25 | Common equity | Long | USA |
CDMO Avid Bioservices, Inc. | 83.29 k | 6.74 k shares | 0.23 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 81.46 k | 9.35 k shares | 0.23 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 80.60 k | 10.33 k shares | 0.22 | Common equity | Long | USA |
XNCR Xencor, Inc. | 76.71 k | 3.34 k shares | 0.21 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 74.95 k | 14.84 k shares | 0.21 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 74.30 k | 4.99 k shares | 0.21 | Common equity | Long | USA |
ALT Altimmune, Inc. | 73.06 k | 10.13 k shares | 0.20 | Common equity | Long | USA |
HSBC SECURITIES (USA), INC. B 4.2 , 1/01/2024 | 72.00 k | 72.00 k principal | 0.20 | Repurchase agreement | Long | USA |
ANNX Annexon, Inc. | 71.95 k | 14.03 k shares | 0.20 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 70.14 k | 5.76 k shares | 0.19 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 69.10 k | 4.99 k shares | 0.19 | Common equity | Long | Ireland |
IRWD Ironwood Pharmaceuticals, Inc. | 67.36 k | 15.21 k shares | 0.19 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 66.04 k | 16.03 k shares | 0.18 | Common equity | Long | USA |
GRAL GRAIL, Inc. | 64.10 k | 3.59 k shares | 0.18 | Common equity | Long | USA |
SOCIETE' GENERALE C 4.3 , 1/01/2024 | 64.00 k | 64.00 k principal | 0.18 | Repurchase agreement | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 62.77 k | 3.70 k shares | 0.17 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 60.28 k | 4.55 k shares | 0.17 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 60.14 k | 4.97 k shares | 0.17 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 56.91 k | 7.75 k shares | 0.16 | Common equity | Long | USA |
IMNM Immunome, Inc. | 55.51 k | 5.23 k shares | 0.15 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 51.47 k | 4.79 k shares | 0.14 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 50.27 k | 23.60 k shares | 0.14 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 49.42 k | 8.76 k shares | 0.14 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 47.64 k | 4.32 k shares | 0.13 | Common equity | Long | USA |
ArriVent Biopharma Inc
|
46.70 k | 1.75 k shares | 0.13 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 46.58 k | 6.03 k shares | 0.13 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 46.56 k | 2.94 k shares | 0.13 | Common equity | Long | USA |
NATWEST MARKETS PLC 4.33 , 1/01/2024 | 46.00 k | 46.00 k principal | 0.13 | Repurchase agreement | Long | USA |
ETNB 89bio, Inc. | 44.57 k | 5.70 k shares | 0.12 | Common equity | Long | USA |
DNTH Dianthus Therapeutics, Inc. | 39.85 k | 1.83 k shares | 0.11 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 38.88 k | 1.92 k shares | 0.11 | Common equity | Long | USA |
CREDIT AGRICOLE CIB NY A 4.3 , 1/01/2024 | 38.00 k | 38.00 k principal | 0.11 | Repurchase agreement | Long | USA |
ERAS Erasca, Inc. | 33.82 k | 13.47 k shares | 0.09 | Common equity | Long | USA |
LENZ LENZ Therapeutics, Inc. | 32.88 k | 1.14 k shares | 0.09 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 32.86 k | 20.16 k shares | 0.09 | Common equity | Long | USA |
MDXG MiMedx Group, Inc. | 31.05 k | 3.23 k shares | 0.09 | Common equity | Long | USA |
UMB FINANCIAL CORP. 4.15 , 1/01/2024 | 31.00 k | 31.00 k principal | 0.09 | Repurchase agreement | Long | USA |
ABUS Arbutus Biopharma Corporation | 30.83 k | 9.43 k shares | 0.09 | Common equity | Long | Canada |
OLMA Olema Pharmaceuticals, Inc. | 30.49 k | 5.23 k shares | 0.08 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 30.38 k | 2.11 k shares | 0.08 | Common equity | Long | USA |
KalVista Pharmaceuticals, Inc.
|
29.63 k | 3.50 k shares | 0.08 | Common equity | Long | USA |
SVRA Savara Inc. | 28.99 k | 9.44 k shares | 0.08 | Common equity | Long | USA |
TSHA Taysha Gene Therapies, Inc. | 28.03 k | 16.20 k shares | 0.08 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 26.64 k | 3.30 k shares | 0.07 | Common equity | Long | USA |
CELC Celcuity Inc. | 25.96 k | 1.98 k shares | 0.07 | Common equity | Long | USA |
ROYAL BANK OF CANADA 4.28 , 1/01/2024 | 25.00 k | 25.00 k principal | 0.07 | Repurchase agreement | Long | USA |
SGMO Sangamo Therapeutics, Inc. | 23.02 k | 22.57 k shares | 0.06 | Common equity | Long | USA |
AKBA Akebia Therapeutics, Inc. | 21.94 k | 11.55 k shares | 0.06 | Common equity | Long | USA |
ATXS Astria Therapeutics, Inc. | 21.57 k | 2.41 k shares | 0.06 | Common equity | Long | USA |
YMAB Y-mAbs Therapeutics, Inc. | 20.75 k | 2.65 k shares | 0.06 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 12.34 k | 1.78 k shares | 0.03 | Common equity | Long | USA |
VPBT_SPSIBI_GOLDMAN
GOLDMAN SACHS GROUP, INC.
|
-5.54 k | 38.00 other units | -0.02 | Equity derivative | Long | USA |